Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001936308 | SCV002201833 | uncertain significance | Hereditary hemorrhagic telangiectasia | 2021-08-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ENG protein function. This variant has not been reported in the literature in individuals affected with ENG-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with phenylalanine at codon 169 of the ENG protein (p.Leu169Phe). The leucine residue is weakly conserved and there is a small physicochemical difference between leucine and phenylalanine. |
Fulgent Genetics, |
RCV002484613 | SCV002776424 | uncertain significance | Telangiectasia, hereditary hemorrhagic, type 1 | 2021-11-08 | criteria provided, single submitter | clinical testing |